Delivery Order SPE2DB20D2014-SPE2DB25FC26K
- Not listed
- The Defense Logistics Agency awarded a $118,710 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561999998 Buprenorphine-Naloxone 2-0.5mg sublingual filmstrips in 30-count packages. Performance will take place at the contractor's facility located in Conshohocken, Pennsylvania. The order is associated with an existing indefinite-delivery/indefinite-quantity pharmaceutical contract held by Amerisourcebergen to support the medical treatment programs of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the provision of buprenorphine-naloxone 8-2 milligram film, a specialty pharmaceutical product, with a ceiling value of $1,598.45 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a major supplier of pharmaceuticals and...
- The Defense Logistics Agency awarded a $2,778.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Buprenorphine 0.3 mg/mL vials. This contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, involves no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty-six dollars and ten cents to Amerisourcebergen Drug Corporation for buprenorphine-naloxone sublingual tablets. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 9, 2023 in accordance with the terms of the order. The Defense Logistics Agency utilizes such contracts and delivery orders to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Buprenorphine 2 mg tablets in 30-count packages at a ceiling value of $1,442.88. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 15, 2025. The contract will be fulfilled from AmerisourceBergen's Pennsylvania facility, supporting...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for Buprenorphine 15 mcg 4s under a Firm Fixed Price contract valued at $1,353.60. The award, issued on April 24, 2025, with an ultimate completion date of May 21, 2025, represents a competitive, non-set-aside procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, a...
- The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the supply of 2 mg buprenorphine tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 30-count bottles of the tablets to a location in Conshohocken, Pennsylvania by August 21, 2023 to support Defense Logistics Agency pharmaceutical needs. No set aside designation or subcontractors were identified. This delivery order was issued against an existing DLA pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $137,000 to Amerisourcebergen Drug Corporation for the provision of 8 mg buprenorphine tablets. The firm fixed price order calls for the delivery of 30 boxes containing buprenorphine tablets to a facility in Conshohocken, Pennsylvania, with performance required between July 18-19, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this award supports the DLA's...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $282.29 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561544424 Buprenorphine-Nalox 8-2mg film packages containing 30 strips each. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 19-20, 2023. No major subcontractors or set aside designations were indicated. The Defense...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC26KDelivery Order
The Defense Logistics Agency awarded a $1,323.06 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Suboxone 8 mg-2 mg sublingual film in quantities of 30, with a completion date of June 23, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price transaction and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order derives from AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, routinely fulfills federal medical procurement requirements across multiple therapeutic domains through DLA's Medical Supply Chain. The Suboxone delivery represents a routine pharmaceutical supply transaction consistent with the company's established role as a critical vendor for federal medical agencies, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/20/25 |